Supernus Pharmaceuticals | SUPN - Assets


Supernus Pharmaceuticals reported $1.42B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Eisai JPY 1.44T 28.38B Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Novo Nordisk DKK 512.29B 30.14B Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025